Updated Oct 9, 2026 · 04:30 UTC
ABTAbbott Laboratories
Health Care · United States · XNYS · pharmaceutical preparations
$98.47−0.24%last session · market closed
Market cap
$170.38b
real-world
Tokenized
$1.6m
<0.001% of the asset
Avg token price
$100.09
+1.65% vs real
Spot volume, 24h
$881k
8 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
ABT · Price
Sep 4, 2025low $83.72 · high $136.05 · now $100.13Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 21
before the open · Sep 2026 quarter · EPS forecast $1.43 (8 analysts)
Last earnings, Jul 16
$1.31 EPS
+2.3% vs $1.28 forecast · Jun 2026 quarter
Real market
Abbott Laboratories
Last close
$98.73
Oct 7
Traded on Oct 7
$926.1m
Price now
$98.47
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $881k · 8 venues
XT.COM2 pairs$238k
Gate2 pairs$213k
Ourbit1 pair$163kDerivatives · — · 0 venues
None yet
Onchain versions
3 tokens from 2 issuers
ABTonOndo Assets$100.16$1.4m
ABTXBacked Assets$99.36$238k
WABTXBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
Ethereum85%$1.4m
Solana14%$219k
Ink0.5%$8k
BNB Chain0.3%$4kIn DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Mar 2026 · SEC EDGAR
Results
Revenue
$45.13b
+7% YoY
Operating income
$7.71b
17% margin · +8% YoY
Net income
$6.28b
14% margin · −54% YoY
EPS, diluted
$3.59
−54% YoY
Cash and balance sheet
Free cash flow
$7.38b
16% of revenue
Net debt
$26.75b
$7.29b cash and securities, $34.05b debt
Diluted shares
1.75b
−0% YoY
Valuation at today’s market cap
P/E
27×
EV / sales
4.4×
enterprise value $197.13b
EV / operating income
25.6×
Free cash flow yield
4.3%
Quarterly
RevenueNet income